Ayala Pharmaceuticals, Inc. reports

Company location: Monmouth Junction, NJ
Fiscal year end: 31 December

Ayala Pharmaceuticals, Inc. has filed 1,330 SEC EDGAR filings since 14 Dec 1999

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 601-625 of 1,000 matching filings.

Per page

25

Current page

25

4

4 filing

Filing date: 04 Aug 2015
Reporting date: 31 Jul 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Aug 2015
Reporting date: 31 Jul 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Aug 2015
Reporting date: 31 Jul 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Aug 2015
Reporting date: 31 Jul 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 04 Aug 2015
Reporting date: 31 Jul 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 01 Jul 2015
Reporting date: 30 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 01 Jul 2015
Reporting date: 30 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 01 Jul 2015
Reporting date: 30 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 01 Jul 2015
Reporting date: 30 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 01 Jul 2015
Reporting date: 30 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 25 Jun 2015
Reporting date: 25 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

S-8 File 333-204939

S-8 filing

Filing date: 15 Jun 2015
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-36138

10-Q filing

Filing date: 15 Jun 2015
Reporting date: 30 Apr 2015
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

4 filing

Filing date: 02 Jun 2015
Reporting date: 29 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Jun 2015
Reporting date: 29 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Jun 2015
Reporting date: 29 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Jun 2015
Reporting date: 29 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 02 Jun 2015
Reporting date: 29 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 02 Jun 2015
Reporting date: 01 Jun 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 27 May 2015
Reporting date: 27 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 20 May 2015
Reporting date: 20 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-36138

8-K filing

Filing date: 05 May 2015
Reporting date: 05 May 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

ADVAXIS, INC.

Filing date: 04 May 2015
Reporting date: 30 Apr 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 01 May 2015
Reporting date: 30 Apr 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

4

4 filing

Filing date: 01 May 2015
Reporting date: 30 Apr 2015
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .